Developer docs
API playgroundTry for free, no card

Search company profiles

Diagnostics For All

Full company profile

uuid000bnha

Namestring
Diagnostics For All
Legal namestring
Diagnostics for All
Websiteurl
dfa.org
Company typeenum
Private
Founded yearint
2007
Descriptiontext

Diagnostics For All (DFA) is a non-profit enterprise based in Salem, United States, founded in 2007 to develop low-cost diagnostic tools for healthcare and agricultural applications in the developing world. The organization focuses on populations and healthcare facilities lacking access to conventional laboratory infrastructure, with a stated mission of saving lives and improving health outcomes in resource-limited settings.

The company's core technology is paper microfluidics — diagnostic devices built on paper substrates that enable point-of-care testing without the need for laboratory equipment. This approach is positioned as a cost-efficient alternative to traditional lab diagnostics, targeting use cases such as early disease detection in remote or under-resourced environments. DFA offers a portfolio of paper-based diagnostic products in this category.

As a non-profit, Diagnostics For All does not operate a traditional commercial revenue model; pricing is not publicly disclosed and the organization is structured for social impact rather than shareholder returns. Distribution and awareness are described as likely channeled through partnerships with international health organizations, NGOs, and government health ministries rather than conventional commercial distribution. The company is co-founded by Hayat al-Sindi (PhD in biotechnology, University of Cambridge, 2001) and chaired by Carmichael Roberts.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersCambridge, United States
HQ citystring
Cambridge
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
paper microfluidics diagnostics, point-of-care testing, low-cost diagnostic devices, resource-limited healthcare, developing world diagnostics
Industry1 code
PRIMARYHLAHACAL
Remote Diagnostics & Home Testing Devices (Connected POC/At-Home Diagnostic Readers)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Patient Monitoring, Wearables & Remote Diagnostics
NAICS code1 code
  • Surgical and Medical Instrument Manufacturing339112
SIC code2 codes
  • In Vitro & In Vivo Diagnostic Substances2835
  • Surgical & Medical Instruments & Apparatus3841
Product category
Point-of-Care Diagnostics
Social media profiles2 records
Cost components3 values
Technology or R&D, Personnel, Operations
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Diagnostics For All develops and produces low-cost paper-based diagnostic tools using proprietary paper microfluidics technology. The devices are designed for point-of-care testing in resource-limited healthcare settings in the developing world, where conventional laboratory diagnostics are unavailable or unaffordable, enabling early disease detection and improved health outcomes in underserved populations.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Diagnostics For All (DFA) is a non-profit enterprise that creates low-cost paper-based diagnostic tools. The organization fuses biotechnology and device development to address health challenges in developing regions. The company offers a portfolio of paper-based diagnostic products designed for point-of-care use in low-resource environments.

Product and service1 record
1Low-Cost Paper-Based Diagnostic Tools
CategoryPoint-of-Care Diagnostics
Description

Non-profit diagnostic tools utilizing paper microfluidics technology, designed for low-cost, point-of-care testing in resource-limited healthcare settings in the developing world where conventional laboratory infrastructure is unavailable.

Scale indicator2 records

Each record includes

Type, Value, Description, Source

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Large diagnostics company with rapid immunoassay and POC products used in clinical and global health settings. Comparable in product class (rapid diagnostics) but with a much broader and more commercial portfolio.

TypeBroad incumbent
Description

Danaher-owned POC diagnostics franchise focused on hemoglobin, glucose, and other blood-based rapid tests, with significant deployment in global health and emerging markets. Comparable POC diagnostic platform serving overlapping customer needs in resource-limited settings.

TypeDirect peer
Description

UK-based developer of lateral flow and rapid diagnostic tests focused on global health, agricultural, and at-home applications. Highly comparable to DFA in mission, technology class (rapid diagnostics), and target customer segments in the developing world.

TypeDirect peer
Description

Developer of integrated rapid diagnostic test platforms (e.g., HIV, malaria) designed for use in low-resource settings. Direct competitor in the low-cost POC diagnostics category serving global health markets.

TypeBroad incumbent
Description

Large life science and clinical diagnostics manufacturer with significant global health and infectious disease diagnostic offerings. Overlaps with DFA in the broader diagnostics category, though Bio-Rad is substantially larger and more diversified.

TypeBroad incumbent
Description

Public POC diagnostics company with a portfolio of rapid tests for infectious disease, sexual health, and tropical diseases. Comparable in product category and end markets, though Chembio operates a broader commercial portfolio at greater scale.

TypeBroad incumbent
Description

UK-listed POC diagnostics company with a broad portfolio of hemoglobin, glucose, and infectious disease rapid tests sold globally, including in developing-world healthcare channels. Overlapping POC category and customer base.

TypeEmerging player
Description

Originally a paper microfluidics-focused developer acquired by Sony, working on cartridge-based POC diagnostic devices. Direct technology-class peer to DFA in paper microfluidics, though now operating within a large parent and focused on commercialized cartridge products.

9Diagnostics for the Real World
TypeDirect peer
Description

Cambridge-spinout (founded by Helen Lee) developing low-cost, rapid POC diagnostic tests for HIV and other infectious diseases in resource-limited settings. The most direct peer to Diagnostics For All given the shared mission of low-cost POC diagnostics for the developing world.

10Abbott Point of Care
TypeBroad incumbent
Description

A business unit of Abbott focused on POC diagnostics (e.g., i-STAT), serving hospitals and global health programs. A broad incumbent whose POC platform directly competes for the same institutional and global-health buyers DFA targets.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature1 record

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Diagnostics For All

Point-of-Care Diagnosticsdfa.org

What Diagnostics For All does

Diagnostics For All (DFA) is a non-profit enterprise based in Salem, United States, founded in 2007 to develop low-cost diagnostic tools for healthcare and agricultural applications in the developing world. The organization focuses on populations and healthcare facilities lacking access to conventional laboratory infrastructure, with a stated mission of saving lives and improving health outcomes in resource-limited settings.

The company's core technology is paper microfluidics — diagnostic devices built on paper substrates that enable point-of-care testing without the need for laboratory equipment. This approach is positioned as a cost-efficient alternative to traditional lab diagnostics, targeting use cases such as early disease detection in remote or under-resourced environments. DFA offers a portfolio of paper-based diagnostic products in this category.

As a non-profit, Diagnostics For All does not operate a traditional commercial revenue model; pricing is not publicly disclosed and the organization is structured for social impact rather than shareholder returns. Distribution and awareness are described as likely channeled through partnerships with international health organizations, NGOs, and government health ministries rather than conventional commercial distribution. The company is co-founded by Hayat al-Sindi (PhD in biotechnology, University of Cambridge, 2001) and chaired by Carmichael Roberts.

Diagnostics For All firmographics

Firmographics
Name
Diagnostics For All
Legal name
Diagnostics for All
Website
https://dfa.org
Company type
Private
Founded year
2007
Operating status
Operating
Headcount range
11–50 employees
Ownership category
akta.pro rank

Diagnostics For All industry classification

Industry
Product category
Point-of-Care Diagnostics
NAICS
Surgical and Medical Instrument Manufacturing (339112)
SIC
In Vitro & In Vivo Diagnostic Substances (2835), Surgical & Medical Instruments & Apparatus (3841)
akta.pro industry
PRIMARYHLAHACAL
Remote Diagnostics & Home Testing Devices (Connected POC/At-Home Diagnostic Readers)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Patient Monitoring, Wearables & Remote Diagnostics

Keywords

  • Paper microfluidics diagnostics
  • Point-of-care testing
  • Low-cost diagnostic devices
  • Resource-limited healthcare
  • Developing world diagnostics

Where Diagnostics For All is headquartered

Location

Headquarters

HQ city
Cambridge
HQ country
United States
HQ region
North America

Markets served

Diagnostics For All business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Personnel, Operations

Diagnostics For All product offering

Product offering

Core offering

Diagnostics For All develops and produces low-cost paper-based diagnostic tools using proprietary paper microfluidics technology. The devices are designed for point-of-care testing in resource-limited healthcare settings in the developing world, where conventional laboratory diagnostics are unavailable or unaffordable, enabling early disease detection and improved health outcomes in underserved populations.

Product overview

Diagnostics For All (DFA) is a non-profit enterprise that creates low-cost paper-based diagnostic tools. The organization fuses biotechnology and device development to address health challenges in developing regions. The company offers a portfolio of paper-based diagnostic products designed for point-of-care use in low-resource environments.

Differentiator

Problem solved

Functional benefit

Products and services

  • Low-Cost Paper-Based Diagnostic Tools Non-profit diagnostic tools utilizing paper microfluidics technology, designed for low-cost, point-of-care testing in resource-limited healthcare settings in the developing world where conventional laboratory infrastructure is unavailable.

Companies that use Diagnostics For All

Customer profile

Segments1 record

Ideal customer profiles1 record

Diagnostics For All technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature1 record

Diagnostics For All partnerships and signals

Strategic signal

Scale indicators2 records

Recent moves5 records

Expansion highlights4 records

Diagnostics For All competitors and assessment

Company assessment

Broad incumbents

  • QuidelOrtho: Large diagnostics company with rapid immunoassay and POC products used in clinical and global health settings. Comparable in product class (rapid diagnostics) but with a much broader and more commercial portfolio.
  • HemoCue (Danaher): Danaher-owned POC diagnostics franchise focused on hemoglobin, glucose, and other blood-based rapid tests, with significant deployment in global health and emerging markets. Comparable POC diagnostic platform serving overlapping customer needs in resource-limited settings.
  • Bio-Rad Laboratories: Large life science and clinical diagnostics manufacturer with significant global health and infectious disease diagnostic offerings. Overlaps with DFA in the broader diagnostics category, though Bio-Rad is substantially larger and more diversified.
  • Chembio Diagnostics: Public POC diagnostics company with a portfolio of rapid tests for infectious disease, sexual health, and tropical diseases. Comparable in product category and end markets, though Chembio operates a broader commercial portfolio at greater scale.
  • EKF Diagnostics: UK-listed POC diagnostics company with a broad portfolio of hemoglobin, glucose, and infectious disease rapid tests sold globally, including in developing-world healthcare channels. Overlapping POC category and customer base.
  • Abbott Point of Care: A business unit of Abbott focused on POC diagnostics (e.g., i-STAT), serving hospitals and global health programs. A broad incumbent whose POC platform directly competes for the same institutional and global-health buyers DFA targets.

Direct peers

  • Mologic: UK-based developer of lateral flow and rapid diagnostic tests focused on global health, agricultural, and at-home applications. Highly comparable to DFA in mission, technology class (rapid diagnostics), and target customer segments in the developing world.
  • Atomo Diagnostics: Developer of integrated rapid diagnostic test platforms (e.g., HIV, malaria) designed for use in low-resource settings. Direct competitor in the low-cost POC diagnostics category serving global health markets.
  • Diagnostics for the Real World: Cambridge-spinout (founded by Helen Lee) developing low-cost, rapid POC diagnostic tests for HIV and other infectious diseases in resource-limited settings. The most direct peer to Diagnostics For All given the shared mission of low-cost POC diagnostics for the developing world.

Emerging players

  • Micronics (Sony): Originally a paper microfluidics-focused developer acquired by Sony, working on cartridge-based POC diagnostic devices. Direct technology-class peer to DFA in paper microfluidics, though now operating within a large parent and focused on commercialized cartridge products.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

Diagnostics For All social profiles

Digital presence

Diagnostics For All financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Diagnostics For All leadership team

Management profile

Number of profiles

Profiles2 records

Diagnostics For All funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Diagnostics For All M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Diagnostics For All

What does Diagnostics For All do?

Diagnostics For All develops and produces low-cost paper-based diagnostic tools using proprietary paper microfluidics technology. The devices are designed for point-of-care testing in resource-limited healthcare settings in the developing world, where conventional laboratory diagnostics are unavailable or unaffordable, enabling early disease detection and improved health outcomes in underserved populations.

Is Diagnostics For All a public or private company?

Diagnostics For All is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was Diagnostics For All founded?

Diagnostics For All was founded in 2007. It employs 11 to 50 people.

Where is Diagnostics For All based?

Diagnostics For All is headquartered in Cambridge, United States, in the North America region.

Who are Diagnostics For All's main competitors?

Broad incumbents on record are QuidelOrtho, HemoCue (Danaher), Bio-Rad Laboratories, Chembio Diagnostics, EKF Diagnostics and Abbott Point of Care. Direct peers are Mologic, Atomo Diagnostics and Diagnostics for the Real World. Micronics (Sony) is listed as an emerging player.

Does Diagnostics For All have an API?

No public API is recorded for Diagnostics For All.

What industry is Diagnostics For All in?

Diagnostics For All's product category is Point-of-Care Diagnostics. Its primary akta.pro industry code is HLAHACAL, Remote Diagnostics & Home Testing Devices (Connected POC/At-Home Diagnostic Readers). Its NAICS code is 339112 and its SIC code is 2835.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals